Figure 3

Validation of the disulfidptosis-associated lncRNA model. (A) PCA of model-related lncRNAs. (B) tSNE analysis of model-related lncRNAs. (C) Progression-free survival analysis. (D–F) The overall survival of the TCGA set, the testing set and the training set. (G–I) The risk index of the high- and low-risk groups in the three sets. (J–L) The model lncRNA expression of the high- and low-risk groups in the three sets. (M) Overall survival analysis of GIHCG in external datasets.